Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder
The treatment recommendations in obsessive-compulsive disorder (OCD) after lack of response to selective serotonin reuptake inhibitors (SSRIs) include augmentation with other drugs, particularly clomipramine, a more potent serotonin reuptake inhibitor (SRI), or antipsychotics. We present two cases o...
Main Authors: | Manuel Arrojo-Romero, María Tajes Alonso, Jose de Leon |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2013/612459 |
Similar Items
-
Lamotrigine Augmentation versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial
by: Mohammadrasoul Khalkhali, et al.
Published: (2016-06-01) -
Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
by: Giuseppe Maina, et al.
Published: (2009-03-01) -
Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
by: Natan Pereira Gosmann, et al.
Published: (2021-06-01) -
Comparing Attention Bias Modification With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
by: Khadijeh Mohsenpourian, et al.
Published: (2019-09-01) -
Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients
by: Mohsen Dadashi, et al.
Published: (2020-01-01)